论文标题
深度学习的计算病理学预测了未知主要的癌症的起源
Deep Learning-based Computational Pathology Predicts Origins for Cancers of Unknown Primary
论文作者
论文摘要
未知的原发性(杯子)癌是一组神秘的诊断群,其中无法确定肿瘤起源的主要解剖部位。这构成了巨大的挑战,因为现代治疗方法(例如化学疗法方案和免疫检查点抑制剂)特有原发性肿瘤。最近的工作集中在使用基因组学和转录组学来鉴定肿瘤起源。但是,并非针对每个患者进行基因组测试,并且在低资源环境中缺乏临床渗透。在此,为了克服这些挑战,我们提出了一种基于深度学习的计算病理学算法 - 可以使用常规获得的组织学幻灯片为杯子提供鉴别诊断。我们使用了17,486 Gigapixel的全滑动图像,其中已知的原则分布在18个常见起源上,以训练多任务深层模型,以同时将肿瘤识别为主要或转移性的肿瘤,并预测其原产地点。我们在4,932个病例的内部测试集上测试了模型,并获得了0.84的前1位准确性,前3个精度为0.94,而在我们的外部测试集中,来自202家不同医院的662例外部测试集,它的TOP-1和TOP-3精度分别为0.79和0.93。我们进一步策划了一个来自151个不同医疗中心的717个杯子病例的数据集,并确定了290例分配鉴别诊断的子集。我们的模型预测导致了50%的案例(\ k {appa} = 0.4时,偶然地调整一致时)和75%的前3个协议。我们提出的方法可以用作一种辅助工具,将鉴别诊断分配给复杂的转移性和杯子病例,并可以与或代替免疫组织化学分析和大量诊断检查一起使用,以减少杯赛的发生。
Cancer of unknown primary (CUP) is an enigmatic group of diagnoses where the primary anatomical site of tumor origin cannot be determined. This poses a significant challenge since modern therapeutics such as chemotherapy regimen and immune checkpoint inhibitors are specific to the primary tumor. Recent work has focused on using genomics and transcriptomics for identification of tumor origins. However, genomic testing is not conducted for every patient and lacks clinical penetration in low resource settings. Herein, to overcome these challenges, we present a deep learning-based computational pathology algorithm-TOAD-that can provide a differential diagnosis for CUP using routinely acquired histology slides. We used 17,486 gigapixel whole slide images with known primaries spread over 18 common origins to train a multi-task deep model to simultaneously identify the tumor as primary or metastatic and predict its site of origin. We tested our model on an internal test set of 4,932 cases with known primaries and achieved a top-1 accuracy of 0.84, a top-3 accuracy of 0.94 while on our external test set of 662 cases from 202 different hospitals, it achieved a top-1 and top-3 accuracy of 0.79 and 0.93 respectively. We further curated a dataset of 717 CUP cases from 151 different medical centers and identified a subset of 290 cases for which a differential diagnosis was assigned. Our model predictions resulted in concordance for 50% of cases (\k{appa}=0.4 when adjusted for agreement by chance) and a top-3 agreement of 75%. Our proposed method can be used as an assistive tool to assign differential diagnosis to complicated metastatic and CUP cases and could be used in conjunction with or in lieu of immunohistochemical analysis and extensive diagnostic work-ups to reduce the occurrence of CUP.